The weekly litigation news digest is live. Subscribe now

Endoxifen Methods And Compositions - EP2101731

The patent EP2101731 was granted to Jina Pharmaceuticals on Jan 31, 2018. The application was originally filed on Nov 21, 2007 under application number EP07871563A. The patent is currently recorded with a legal status of "Revoked".

EP2101731

JINA PHARMACEUTICALS
Application Number
EP07871563A
Filing Date
Nov 21, 2007
Status
Revoked
May 19, 2023
Publication Date
Jan 31, 2018
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

BAYEROct 31, 2018MAIWALDADMISSIBLE
BESINS HEALTHCARE MONACO SAMOct 29, 2018NEDERLANDSCH OCTROOIBUREAUADMISSIBLE

Patent Citations (6) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONWO2007US80984
DESCRIPTIONWO2007US83832
INTERNATIONAL-SEARCH-REPORTUS6090407
INTERNATIONAL-SEARCH-REPORTUS6290991
OPPOSITIONUS2005158388
OPPOSITIONWO2008127358

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents